Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B D Prendergast

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Heart (British Cardiac Society)|June 17, 2003
HIV and cardiovascular medicineB D Prendergast
Clinical Pharmacy|September 1, 1984
Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agentsB D Prendergast
BMJ (Clinical Research Ed.)|February 4, 1998
La salle de garde: bastion of the French lunch hour for junior doctorsB D Prendergast
Heart (British Cardiac Society)|October 12, 2005
The changing face of infective endocarditisB D Prendergast
Heart (British Cardiac Society)|May 18, 2004
Diagnostic criteria and problems in infective endocarditisB D Prendergast
BMJ (Clinical Research Ed.)|January 9, 2015
Public healthcare systems should not pay for private profitS Coffey, B D Prendergast
Hospital Medicine (London, England : 1998)|October 5, 2001
Percutaneous balloon mitral valvuloplastyB D Prendergast, S Shaw
Postgraduate Medical Journal|May 1, 1993
Drug-induced rhabdomyolysis--mechanisms and managementB D Prendergast, C F George
European Heart Journal|March 28, 2018
Risk of infective endocarditis after left-sided surgical valve replacementT J Cahill, B D Prendergast
QJM : Monthly Journal of the Association of Physicians|March 17, 2010
Will direct thrombin inhibition change the boundaries of oral anti-coagulation?O Lomas, R A Argyle, B D Prendergast
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Heart (British Cardiac Society)|June 17, 2003
HIV and cardiovascular medicineB D Prendergast
Clinical Pharmacy|September 1, 1984
Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agentsB D Prendergast
BMJ (Clinical Research Ed.)|February 4, 1998
La salle de garde: bastion of the French lunch hour for junior doctorsB D Prendergast
Heart (British Cardiac Society)|October 12, 2005
The changing face of infective endocarditisB D Prendergast
Heart (British Cardiac Society)|May 18, 2004
Diagnostic criteria and problems in infective endocarditisB D Prendergast
BMJ (Clinical Research Ed.)|January 9, 2015
Public healthcare systems should not pay for private profitS Coffey, B D Prendergast
Hospital Medicine (London, England : 1998)|October 5, 2001
Percutaneous balloon mitral valvuloplastyB D Prendergast, S Shaw
Postgraduate Medical Journal|May 1, 1993
Drug-induced rhabdomyolysis--mechanisms and managementB D Prendergast, C F George
European Heart Journal|March 28, 2018
Risk of infective endocarditis after left-sided surgical valve replacementT J Cahill, B D Prendergast
QJM : Monthly Journal of the Association of Physicians|March 17, 2010
Will direct thrombin inhibition change the boundaries of oral anti-coagulation?O Lomas, R A Argyle, B D Prendergast
Pageof 5